Arena Pharmaceuticals, Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-12-31 3 months ending 2014-09-30 3 months ending 2014-06-30 3 months ending 2014-03-31 3 months ending 2013-12-31
Revenue 9.19 8.16 12.80 6.81 6.52
Other Revenue, Total - - - - -
Total Revenue 9.19 8.16 12.80 6.81 6.52
Cost of Revenue, Total 2.59 1.84 2.01 1.33 1.38
Gross Profit 6.61 6.33 10.79 5.49 5.14
Selling/General/Admin. Expenses, Total 8.94 8.03 9.13 8.04 8.07
Research & Development 27.83 24.51 27.02 20.99 19.04
Depreciation/Amortization - - - - 0.00
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.00 - - - 0.00
Other Operating Expenses, Total - - - - -
Total Operating Expense 39.35 34.37 38.17 30.35 28.49
Operating Income -30.16 -26.21 -25.37 -23.54 -21.97
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -1.13 -1.62 0.27 0.11 0.20
Income Before Tax -32.06 -10.67 7.48 -25.25 -23.46
Income After Tax -32.06 -10.67 7.48 -25.25 -23.46
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -32.06 -10.67 7.48 -25.25 -23.46
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -32.06 -10.67 7.48 -25.25 -23.46
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -32.06 -10.67 7.48 -25.25 -23.46
Income Available to Common Incl. Extra Items -32.06 -10.67 7.48 -25.25 -23.46
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - 0.00 0.00
Diluted Weighted Average Shares 220.16 219.87 225.34 219.22 218.65
Diluted EPS Excluding Extraordinary Items -0.15 -0.05 0.03 -0.12 -0.11
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue - 0.00 0.00 0.00 -
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.15 -0.05 0.03 -0.12 -0.11